We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$21.6B
AUM Growth
+$1.94B
Cap. Flow
+$436M
Cap. Flow %
2.02%
Top 10 Hldgs %
28.47%
Holding
769
New
76
Increased
265
Reduced
236
Closed
94

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$130M
2
UNH icon
UnitedHealth
UNH
+$111M
3
ISRG icon
Intuitive Surgical
ISRG
+$86.1M
4
GE icon
GE Aerospace
GE
+$76.1M
5
NVS icon
Novartis
NVS
+$67.3M

Sector Composition

Rank Sector Weight
1 Technology 29.12%
2 Healthcare 19.64%
3 Financials 9.5%
4 Consumer Discretionary 8.67%
5 Communication Services 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$1.03B 4.79%
3,035,240
-265,356
-8% -$83.2M
META icon
2
Meta Platforms (Facebook)
META
$1.54T
$704M 3.26%
2,454,830
-291,152
-11% -$71.8M
UNH icon
3
UnitedHealth
UNH
$385B
$652M 3.02%
1,356,123
+227,882
+20% +$111M
AAPL icon
4
Apple
AAPL
$4.72T
$587M 2.72%
3,025,382
-117,104
-4% -$20.4M
AMZN icon
5
Amazon
AMZN
$2.51T
$577M 2.67%
4,427,325
-333,713
-7% -$38.1M
JNJ icon
6
Johnson & Johnson
JNJ
$624B
$557M 2.58%
3,362,822
+362,803
+12% +$58.6M
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$3.89T
$543M 2.51%
4,533,109
-25,358
-0.6% -$2.92M
ORCL icon
8
Oracle
ORCL
$346B
$524M 2.43%
4,401,629
-29,246
-0.7% -$3.02M
LRCX icon
9
Lam Research
LRCX
$400B
$502M 2.32%
7,811,490
-88,620
-1% -$5M
ACN icon
10
Accenture
ACN
$84.9B
$470M 2.18%
1,524,433
+160,507
+12% +$46.6M
MRK icon
11
Merck
MRK
$322B
$417M 1.93%
3,617,843
+564,296
+18% +$64.1M
TXN icon
12
Texas Instruments
TXN
$260B
$395M 1.83%
2,196,924
+10,004
+0.5% +$1.72M
TJX icon
13
TJX Companies
TJX
$170B
$393M 1.82%
4,634,556
-87,610
-2% -$6.91M
LLY icon
14
Eli Lilly
LLY
$1.06T
$383M 1.77%
816,273
+28,426
+4% +$11.9M
ELV icon
15
Elevance Health
ELV
$82.3B
$369M 1.71%
830,841
+112,802
+16% +$52M
KO icon
16
Coca-Cola
KO
$349B
$353M 1.63%
5,861,699
+281,258
+5% +$17.5M
ADBE icon
17
Adobe
ADBE
$84.3B
$323M 1.5%
660,687
-33,167
-5% -$13.4M
WFC icon
18
Wells Fargo
WFC
$261B
$321M 1.49%
7,528,424
-823,925
-10% -$33.2M
ABT icon
19
Abbott
ABT
$175B
$312M 1.45%
2,863,665
+1,215,172
+74% +$130M
ISRG icon
20
Intuitive Surgical
ISRG
$119B
$303M 1.4%
886,587
+284,564
+47% +$86.1M
CRM icon
21
Salesforce
CRM
$129B
$303M 1.4%
1,432,257
+67,050
+5% +$13.7M
OTIS icon
22
Otis Worldwide
OTIS
$27.2B
$302M 1.4%
3,389,061
+17,255
+0.5% +$1.45M
V icon
23
Visa
V
$669B
$296M 1.37%
1,244,445
+52,634
+4% +$12M
DAR icon
24
Darling Ingredients
DAR
$10.1B
$275M 1.27%
4,309,378
+745,529
+21% +$45.4M
KLAC icon
25
KLA
KLAC
$286B
$264M 1.22%
5,446,570
+269,510
+5% +$11.3M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2023 Portfolio in Review

As of Q2 2023, Grantham, Mayo, Van Otterloo & Co (GMO) held 769 positions worth $21.6B, up 9.9% from $19.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2023 filing shows 76 new, 265 increased, 236 reduced and 94 closed positions. Its largest new stake was GE Aerospace: 940,083 shares worth $82.4M. The largest sale was Medtronic, an estimated $238M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2023 buy was GE Aerospace: 940,083 shares worth $82.4M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Abbott in Q2 2023, an estimated $130M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2023 reduction was Medtronic, cutting an estimated $238M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Occidental Petroleum in Q2 2023, selling an estimated $37.1M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 28% of its $21.6B portfolio in Q2 2023.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 76 new positions and closed 94 in Q2 2023.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 9.9% quarter-over-quarter to $21.6B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2023, filed 14 Aug 2023.